Rapid thickening of aminosilicones to promote emulsion stability and adhesion of UV-curable quantum dot enhancement film emulsions
US-12122948-B2 · Oct 22, 2024 · US
US12139653B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12139653-B2 |
| Application number | US-202217574717-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 13, 2022 |
| Priority date | Jan 13, 2021 |
| Publication date | Nov 12, 2024 |
| Grant date | Nov 12, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to metal halide colloidal nanoparticles represented by a following Chemical Formula 1 and a method for producing the same:A3MX6 [Chemical Formula 1]wherein in the Chemical Formula 1, A is an alkali metal element, M is a rare-earth metal element, and X is a halogen element.
Opening claim text (preview).
What is claimed is: 1. Metal halide colloidal nanoparticles represented by the following Chemical Formula 1: A 3 MX 6 [Chemical Formula 1] wherein in the Chemical Formula 1, A is an alkali metal element, M is a rare-earth metal element, and X is a halogen element, wherein the metal halide colloidal nanoparticles absorb an excitation wavelength in a range of 250 to 320 nm and thus emit light in a light-emission spectrum of 500 to 570 nm or 580 to 630 nm, and wherein the metal halide colloidal nanoparticles absorb an excitation wavelength in a range of 320 to 450 nm and thus emit light in a light-emission spectrum of 380 to 480 nm. 2. The metal halide colloidal nanoparticles of claim 1 , wherein A is Cs, Rb, K, Na, Li, or a combination thereof, M is gadolinium (Gd), yttrium (Y), ytterbium (Yb), erbium (Er), europium (Eu), cerium (Ce), terbium (Tb), or a combination thereof, and X is F, Cl, Br, I, or a combination thereof. 3. The metal halide colloidal nanoparticles of claim 1 , wherein an average particle diameter of each of the metal halide colloidal nanoparticles is in a range of 1 to 100 nm. 4. The metal halide colloidal nanoparticles of claim 1 , wherein a surface of the metal halide colloidal nanoparticle is coated with an organic ligand. 5. The metal halide colloidal nanoparticles of claim 4 , wherein the organic ligand includes at least one selected from a group consisting of a compound derived from R 1 COOH, a compound derived from R 2 NH 2 , a compound derived from R 2 R 3 NH, a compound derived from R 2 R 3 R 4 N, and a compound derived from a first non-polar solvent, wherein R 1 , R 2 , R 3 and R 4 are the same as or different from each other, and each of R 1 , R 2 , R 3 and R 4 independently represents a saturated or unsaturated alkyl group having 2 to 28 carbon atoms. 6. The metal halide colloidal nanoparticles of claim 5 , which are coated with an organic ligand including a compound derived from R 1 COOH, wherein R 1 COOH comprises one acid selected from a group consisting of oleic acid, stearic acid, myristic acid, lauric acid, palmitic acid, elaidic acid, eicosanoic acid, heneicosanoic acid, tricosanoic acid, docosanoic acid, tetracosanoic acid, hexacosanoic acid, heptacosanoic acid, octacosanoic acid, and cis-13-docosenoic acid. 7. The metal halide colloidal nanoparticles of claim 5 , which are coated with an organic ligand including a compound derived from R 2 NH 2 , or a compound derived from R 2 R 3 NH, or a compound derived from R 2 R 3 R 4 N, wherein R 2 NH 2 comprises one amine selected from a group consisting of octylamine, nonylamine, heptylamine, hexylamine, pentylamine, hexadecanamine, octadecylamine, dodecylamine, and oleylamine, wherein R 2 R 3 NH comprises one amine selected from a group consisting of dimethylamine, diethylamine, dipropylamine, and dioctylamine, wherein R 2 R 3 R 4 N comprises trioctylamine. 8. The metal halide colloidal nanoparticles of claim 5 , wherein the first non-polar solvent comprises at least one solvent selected from a group consisting of heptadecane, nonadecane, octadecene, heptadecane, dodecane, or octadecane. 9. A method for producing metal halide colloidal nanoparticles, the method comprising: (a) preparing a mixed solution including R 1 COOH, R 2 NH 2 , R 2 R 3 NH, or R 2 R 3 R 4 N, and a first non-polar solvent, wherein R 1 , R 2 , R 3 and R 4 are the same as or different from each other, and each of R 1 , R 2 , R 3 and R 4 independently represents a saturated or unsaturated alkyl group having 2 to 28 carbon atoms; (b) adding an alkali metal precursor and a rare-earth metal precursor to the mixed solution and stirring the mixed solution to produce a stirred solution; and (c) reacting the stirred solution to produce metal halide colloidal nanoparticles represented by a following Chemical Formula 1, A 3 MX 6 [Chemical Formula 1] wherein in the Chemical Formula 1, A is an alkali metal element, M is a rare-earth metal element, and X is a halogen element. 10. The method of claim 9 , wherein A is Cs, Rb, K, Na, Li, or a combination thereof, M is gadolinium (Gd), yttrium (Y), ytterbium (Yb), erbium (Er), europium (Eu), cerium (Ce), terbium (Tb), or a combination thereof, and X is F, Cl, Br, I, or a combination thereof. 11. The method of claim 9 , wherein R 1 COOH comprises one acid selected from a group consisting of oleic acid, stearic acid, myristic acid, lauric acid, palmitic acid, elaidic acid, eicosanoic acid, heneicosanoic acid, tricosanoic acid, docosanoic acid, tetracosanoic acid, hexacosanoic acid, heptacosanoic acid, octacosanoic acid, and cis-13-docosenoic acid. 12. The method of claim 9 , wherein R 2 NH 2 comprises one amine selected from a group consisting of octylamine, nonylamine, heptylamine, hexylamine, pentylamine, hexadecanamine, octadecylamine, dodecylamine, and oleylamine, wherein R 2 R 3 NH comprises one amine selected from a group consisting of dimethylamine, diethylamine, dipropylamine, and dioctylamine, wherein R 2 R 3 R 4 N comprises trioctylamine. 13. The method of claim 9 , wherein in the (a), R 1 COOH: R 2 NH 2 , or R 1 COOH: R 2 R 3 NH, or R 1 COOH: R 2 R 3 RAN are mixed with each other in a molar ratio of 1:0.5 to 2, and R 1 COOH: the first non-polar solvent is mixed with each other in a molar ratio of 1:10 to 40. 14. The method of claim 9 , wherein the (b) comprises producing the stirred solution by stirring the mixed solution in a vacuum state at 100 to 150° C. for 1 to 10 hours. 15. The method of claim 9 , wherein the (c) comprises producing metal halide colloidal nanoparticles by reacting the stirred solution at 200 to 285° C. for 15 to 120 minutes under presence of an inert gas. 16. A light emitting device including the metal halide colloidal nanoparticles of claim 1 .
with alkali or alkaline earth metals · CPC title
Nanooptics, e.g. quantum optics or photonic crystals · CPC title
Nanometer sized, i.e. from 1-100 nanometer · CPC title
non-luminescent particle coatings or suspension media · CPC title
Manufacture or treatment of nanostructures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.